Published in Cardiovascular Week, January 25th, 2010
"We investigated the association of common ESR2 variants with risk factors for cardiovascular disease and with the severity of CAD in postmenopausal women. ESR2 polymorphisms AluI (1730 G>A) and RsaI (1082 G>A) were studied in 174 postmenopausal women undergoing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2010-01-25)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.